Distinguished in Adenosine Monophosphate Deaminase Deficiency

Lisa Ehlers

Berlin, BE, DE 
Distinguished in Adenosine Monophosphate Deaminase Deficiency
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Lisa Ehlers practices in Berlin, Germany. Ms. Ehlers is rated as a Distinguished expert by MediFind in the treatment of Adenosine Monophosphate Deaminase Deficiency. Her top areas of expertise are Adenosine Monophosphate Deaminase Deficiency, Severe Combined Immunodeficiency (SCID), Giant Cell Arteritis (GCA), and Temporal Arteritis.

Her clinical research consists of co-authoring 19 peer reviewed articles. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Berlin, BE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

19 Total Publications

Dominant negative ADA2 mutations cause ADA2 deficiency in heterozygous carriers.
Dominant negative ADA2 mutations cause ADA2 deficiency in heterozygous carriers.
Journal: The Journal of experimental medicine
Published: March 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ehlers's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile